- Home
- BGI vs ACHL Comparison
BGI vs ACHL Comparison
Compare BGI & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BGI
- ACHL
- Stock Information
- Founded
- BGI 1879
- ACHL 2016
- Country
- BGI Canada
- ACHL United Kingdom
- Employees
- BGI N/A
- ACHL N/A
- Industry
- BGI
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BGI
- ACHL Health Care
- Exchange
- BGI Nasdaq
- ACHL Nasdaq
- Market Cap
- BGI 41.6M
- ACHL 40.4M
- IPO Year
- BGI 2005
- ACHL 2021
- Fundamental
- Price
- BGI $1.59
- ACHL $1.06
- Analyst Decision
- BGI
- ACHL Hold
- Analyst Count
- BGI 0
- ACHL 3
- Target Price
- BGI N/A
- ACHL $2.83
- AVG Volume (30 Days)
- BGI 33.7K
- ACHL 146.9K
- Earning Date
- BGI 12-03-2024
- ACHL 11-14-2024
- Dividend Yield
- BGI N/A
- ACHL N/A
- EPS Growth
- BGI N/A
- ACHL N/A
- EPS
- BGI N/A
- ACHL N/A
- Revenue
- BGI $136,823,177.00
- ACHL N/A
- Revenue This Year
- BGI N/A
- ACHL N/A
- Revenue Next Year
- BGI N/A
- ACHL N/A
- P/E Ratio
- BGI N/A
- ACHL N/A
- Revenue Growth
- BGI 13.70
- ACHL N/A
- 52 Week Low
- BGI $1.53
- ACHL $0.63
- 52 Week High
- BGI $4.88
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- BGI 11.98
- ACHL 60.69
- Support Level
- BGI $1.53
- ACHL $1.01
- Resistance Level
- BGI $2.19
- ACHL $1.08
- Average True Range (ATR)
- BGI 0.16
- ACHL 0.04
- MACD
- BGI -0.05
- ACHL -0.00
- Stochastic Oscillator
- BGI 8.21
- ACHL 53.85
About BGI Birks Group Inc.
Birks Group Inc is a part of the leisure industry. The company designs, develops, produces, and retails fine jewelry, timepieces, and gifts. Its operating segments include Retail and Other. The company generates maximum revenue from the Retail segment. Its retail segment consists of retail operations whereby it operates stores in Canada under the Maison Birks, Brinkhaus, Graff, and Patek Phillippe brands. The other segment consists mainly of wholesale business, e-commerce business, and gold exchange business.
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.